JPRN-UMIN000002697招募中2 期
Phase II trial of docetaxel (T), cisplatin (P) and fluorouracil (5-FU) in the treatment of metastatic penile cancer - TPF in penile cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 75years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Usage of experimental drugs 2) History of serious drug allergy or hypersensitivity with cisplatin or paclitaxel 3) Peripheral neuropathy 4) Ototoxicity 5) Uncontrolled infection 6) Double cancer 7) Coexisting severe medical conditions 8) Mental disease 9) Judged as inappropriate to participate this trial by investigators
研究者
相似试验
已完成
不适用
Phase II trial of docetaxel+cisplatin+capecitabine (DCX) therapy for unresectable or recurrent HER2-negative gastric cancerGastric cancerJPRN-UMIN000026722Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital35
已完成
不适用
A phase II trial of cisplatin, docetaxel and bevacizumab followed by maintenance pemetrexed and bevacizumab in metastatic non-small-cell lung cancerJPRN-UMIN000004127Okayama Lung Cancer Study Group40
已完成
2 期
Multicenter phase II study of docetaxel/cisplatin/bevacizumab combination therapy in patients with advanced non-squamous non-small cell lung cancer (TORG1016)JPRN-UMIN000004368Thoracic Oncology Research Group47
已完成
1 期
Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancergastric cancerJPRN-UMIN000011625Yokohama City University Medical Center51
进行中（未招募）
1 期
A Phase II Trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic carcinoma of the penis - Penile TPFocally advanced and metastatic carcinoma of the penisMedDRA version: 13.1Level: LLTClassification code 10034299Term: Penile cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-000707-28-GBThe Institute of Cancer Research29